What is LUNGevity Foundation?
LUNGevity Foundation operates as the nation's premier lung cancer organization, dedicated to improving patient outcomes through a multifaceted approach that integrates research, policy advocacy, and direct patient support. The organization distinguishes itself by addressing the entire care continuum, from early detection and clinical trial accessibility to survivorship and health equity. By providing medically vetted resources and fostering an active community, LUNGevity serves as a vital bridge between clinical innovation and patient empowerment. Its status as a four-star Charity Navigator organization highlights its operational excellence and fiscal transparency, making it a trusted entity for stakeholders and donors alike.
How much funding has LUNGevity Foundation raised?
LUNGevity Foundation has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in LUNGevity Foundation
PPP
Public-Private Partnership
What's next for LUNGevity Foundation?
Looking ahead, the foundation is poised to leverage its recent capital to deepen its investment in early detection technologies and precision medicine. The strategic roadmap includes scaling the reach of its clinical trial finder and enhancing the efficacy of its public policy initiatives to address systemic health disparities. As the organization continues to amplify the patient voice, the focus will remain on driving survivorship metrics and ensuring that no individual is left behind in the fight against lung cancer. This late-stage funding provides the necessary runway to sustain high-impact programs while exploring new frontiers in medical research and patient-centric care models.
See full LUNGevity Foundation company page